Related Experiment Video
Updated: Jun 22, 2025

09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.1K
Atypical lymphoplasmacytic and immunoblastic proliferation: A Systematic Review
Midori Filiz Nishimura1, Toshiaki Takahashi2, Kensuke Takaoka2
1Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan.
Summary
Atypical lymphoplasmacytic and immunoblastic proliferation (ALPIBP) is often linked to autoimmune diseases but lacks clear definition. Increased awareness is crucial to prevent misdiagnosis of malignancy and unnecessary treatments.
Area of Science:
- Hematopathology
- Immunopathology
- Autoimmune Diseases
Background:
- Atypical lymphoplasmacytic and immunoblastic proliferation (ALPIBP) presents as lymph node findings in autoimmune diseases.
- ALPIBP lacks a clear definition despite its initial report in 1984.
- Distinguishing ALPIBP from malignancies is critical for appropriate patient management.
Approach:
- Systematic literature review of MEDLINE and EMBASE databases.
- Inclusion of 52 cases from 9 articles and 3 institutional cases for analysis.
- Summary of histological characteristics, clinical diagnoses, and treatment outcomes.
Key Points:
- The study analyzed 55 cases of ALPIBP, with a median age of 63.5 years and a female predominance (69.5%).
- Common associated autoimmune conditions include rheumatoid arthritis, SLE, and autoimmune hemolytic anemia.
- Differential diagnoses include T-follicular helper cell lymphoma, methotrexate-associated lymphoproliferative disorders, and IgG4-related diseases.
Conclusions:
- ALPIBP is characterized by specific histological findings often associated with autoimmune conditions.
- Underrecognition of ALPIBP can lead to overdiagnosis of hematological malignancy and unwarranted treatments.
- Enhanced awareness among pathologists and clinicians is essential for accurate diagnosis and management of ALPIBP.
Related Concept Videos
Cells of the Adaptive Immune Response
979
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
979
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K

